(Q35253998)

7 August 2017

title

Oral ciprofloxacin treatment of Pseudomonas aeruginosa osteomyelitis (English)

1 reference

7 August 2017

main subject

Pseudomonas aeruginosa

0 references

1 reference

Dan M

1

1 reference

7 August 2017

Siegman-Igra Y

series ordinal

2

1 reference

7 August 2017

Pitlik S

series ordinal

3

1 reference

7 August 2017

Raz R

series ordinal

4

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 May 1990

1 reference

Antimicrobial Agents and Chemotherapy

7 August 2017

published in

1 reference

7 August 2017

volume

34

1 reference

7 August 2017

issue

5

1 reference

7 August 2017

page(s)

849-852

1 reference

Comparative activities of ciprofloxacin, ticarcillin, and tobramycin against experimental Pseudomonas aeruginosa pneumonia

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171704

Antibiotic susceptibility testing by a standardized single disk method

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171704

Ticarcillin plus clavulanic acid (Timentin) therapy for osteomyelitis.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171704

Imipenem/cilastatin in the treatment of osteomyelitis.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171704

Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171704

Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171704

Oral ciprofloxacin therapy for chronic contiguous osteomyelitis caused by aerobic gram-negative bacilli

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171704

Oral ciprofloxacin therapy for gram-negative bacillary osteomyelitis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171704

Ciprofloxacin: in vitro activity, mechanism of action, and resistance

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171704

Ciprofloxacin as therapy for experimental osteomyelitis caused by Pseudomonas aeruginosa

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171704

Ceftazidime as single-agent therapy for gram-negative aerobic bacillary osteomyelitis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171704

The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171704

Open, prospective study of the clinical efficacy of ciprofloxacin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171704

Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171704

Oral antibiotic therapy for bone and joint infections.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171704

Use of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171704

Evaluation of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171704

Randomized trial of ciprofloxacin compared with other antimicrobial therapy in the treatment of osteomyelitis

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2360823

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Oral antibiotic therapy for skeletal infections of children. II. Therapy of osteomyelitis and suppurative arthritis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2360823

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.34.5.849

1 reference

7 August 2017

1 reference

7 August 2017

1 reference